Delivery Order SPE2DB20D1100-SPE2DB24FA7M5
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $4,530.60. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a completion date of February 28, 2024. AmerisourceBergen Drug Corp is a for-profit organization and the prime contractor on this award, which does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,795.87 firm fixed price delivery order is for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), tasks Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania to deliver TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The award, valued at $9,061.20, is structured as a firm fixed price delivery order with an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,530.60 firm fixed-price delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,265.29 delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through September 30, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting military treatment facilities, veterans' hospitals, and other government...
- This contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $4,530.60 for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of July 31, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, valued at $4,530.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, was awarded a $4,530.60 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medication. The delivery order, which does not have a set-aside designation, has a completion date of March 18, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as a prime contractor...
- This federal contract award, valued at $4,530.60, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a completion date of June 11, 2024. This is a firm fixed-price delivery order contract and was awarded on a full and open competition basis without any set-aside...
- This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $4,530.60 fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024. The contract has an ultimate completion date of July 29, 2024 and was not set aside for a specific business type. Amerisourcebergen holds a single-award Indefinite Delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA7M5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,265.29 firm fixed price delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through April 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not have a set-aside designation and was awarded solely to Amerisourcebergen Drug Corp.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/14/24 |